We want to develop a serial of methods to apply anti-c-Met antibodies in the clinic tumor therapy, for example, developing antibodies that can block the HGF/c-Met pathway, conjugating antibodies with immunotoxins, radioimmunoconjugates and chemotherapy drugs. This evidence concerns the gene HGF and neoplasm.